TIAA CREF Investment Management’s Rocket Pharmaceuticals RCKT Stock Holding History

TIAA CREF Investment Management’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$736K	Hold	41,963	–	–	﹤0.01%	2444
2018 Q4	$622K	Sell	41,963 -378	-0.9%	-$6.28K	﹤0.01%	2476
2018 Q3	$1.04M	Sell	42,341 -4,024	-9%	-$87.3K	﹤0.01%	2404
2018 Q2	$910K	Buy	+46,365	New	+$877K	﹤0.01%	2535
2017 Q2	–	Sell	-13,981	Closed	-$112K	–	3166
2017 Q1	$112K	Hold	13,981	–	–	﹤0.01%	3035
2016 Q4	$341K	Buy	13,981 +1,283	+10%	+$36.6K	﹤0.01%	2948
2016 Q3	$482K	Hold	12,698	–	–	﹤0.01%	2857
2016 Q2	$378K	Buy	+12,698	New	+$446K	﹤0.01%	2971

Other funds holding RCKT

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Bridger Management New York $150M AUM 17.71% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

TIAA CREF Investment Management's RCKT Position: Q1 2019 in Review

TIAA CREF Investment Management held its Rocket Pharmaceuticals (RCKT) position steady in Q1 2019 at 41,963 shares worth $736K. The position accounts for ﹤0.01% of the portfolio, ranked #2444.

TIAA CREF Investment Management first reported a position in RCKT in Q2 2016 and has held it in 8 quarters since. The position peaked at $1.04M in Q3 2018. 81 funds tracked by Wall St. Rank hold RCKT as of Q1 2019.

TIAA CREF Investment Management held 41,963 shares of Rocket Pharmaceuticals worth $736K as of Q1 2019.
TIAA CREF Investment Management left its Rocket Pharmaceuticals share count unchanged in Q1 2019.
Rocket Pharmaceuticals made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2444 holding.
TIAA CREF Investment Management first reported a position in Rocket Pharmaceuticals in Q2 2016 and has held it in 8 quarters since.
TIAA CREF Investment Management's Rocket Pharmaceuticals position peaked at $1.04M in Q3 2018.
81 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.